Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Strata Critical Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Strata Critical Medical, Inc.’s stock price such as:

• Strata Critical Medical, Inc.’s current stock price and volume
• Why Strata Critical Medical, Inc.’s stock price changed recently
• Upgrades and downgrades for SRTA from analysts
• SRTA’s stock price momentum as measured by its relative strength

About Strata Critical Medical, Inc. (SRTA)

Before we jump into Strata Critical Medical, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Want to learn more about Strata Critical Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Strata Critical Medical, Inc..

Strata Critical Medical, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Strata Critical Medical, Inc.’s stock price was $5.020.

Strata Critical Medical, Inc. is down 1.38% from its previous closing price of $5.090.

During the last market session, Strata Critical Medical, Inc.’s stock traded between $4.940 and $5.150. Currently, there are approximately 85.32 million shares outstanding for Strata Critical Medical, Inc..

Strata Critical Medical, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Strata Critical Medical, Inc. Stock Price History

Strata Critical Medical, Inc.’s (SRTA) price is currently down 4.74% so far this month.

During the month of July, Strata Critical Medical, Inc.’s stock price has reached a high of $5.700 and a low of $4.855.

Over the last year, Strata Critical Medical, Inc. has hit prices as high as $6.500 and as low as $3.675. Year to date, Strata Critical Medical, Inc.’s stock is up 4.37%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Strata Critical Medical, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Strata Critical Medical, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Strata Critical Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Strata Critical Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Strata Critical Medical, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Strata Critical Medical, Inc. (SRTA) by visiting AAII Stock Evaluator.

Relative Price Strength of Strata Critical Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Strata Critical Medical, Inc. has a weighted four-quarter relative price strength of 0.60%, which translates to a Momentum Score of 55 and is considered to be Average.

Want to learn more about how Strata Critical Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Strata Critical Medical, Inc. Stock Price: Bottom Line

As of July 31, 2026, Strata Critical Medical, Inc.’s stock price is $5.020, which is down 1.38% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Strata Critical Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.